Everybody Hates Pharma cover art

Everybody Hates Pharma

By: Artem Brytchenko Stefan Repin Ahmed Samir Moustafa Christopher John Bautista
  • Summary

  • In the new season join us in this unique journey, where we dive deep into the pharmaceutical industry, sharing not just stories but also the tools and knowledge that power its progress. "Everybody Hates Pharma" – a podcast that seeks to foster transparency and understanding in the world of pharma.
    © 2024 Artem Brytchenko, Stefan Repin, Ahmed Samir Moustafa, Christopher John Bautista,
    Show More Show Less
Episodes
  • The Future of Pharma: AI, CRM, and Sales – Unveiling Strategies for Success in 2024
    Dec 21 2023
    🎙️ In this podcast episode of 'Pharma Sales and Tech podcast by Platforce', our host Stefan converses with Florent, the Sales SVP of commercial excellence at Grünenthal Group.Florent shares his insights about AI's impact within the pharmaceutical industry and how it's becoming increasingly necessary for advancement. The conversation explores how Grünenthal Group uses AI in its operations and its potential role in pharmaceutical sales and marketing strategies. They also predict an 'AI winter' due to raised and often unmet expectations, and emphasize the need to invest smartly in AI. Furthermore, Florent shares a brief on their internal 'buddy' system, where AI based models are being used for various tasks within the company. Towards the end, Florent advises pharma firms to focus on their field of excellence while adopting technological advancements intelligently.---🔍 Episode Highlights:🚀 1. Navigating the AI Landscape: Florent unpacks the potential benefits and challenges of integrating artificial intelligence in the pharmaceutical industry, emphasizing the need for a smart and strategic approach.🔬 2. Marketing and Sales Synergy: Explore the critical collaboration between marketing and sales teams. Florent advocates for a shift from a product-centric to a customer-centric mindset, highlighting the importance of delivering real value.💼 3. Sales Team Dynamics: Delve into the discussion on in-house sales teams versus external contractors, tailored to the complexity of pharmaceutical products. Discover the nuanced approaches that can enhance sales effectiveness.🤖 4. AI Impact on Personas and Sales Strategies: Florent shares insights on AI-generated personas and the concept of product-focused AI "buddies," offering a glimpse into the potential transformation of sales strategies.🔮 5. Future Predictions: As we look ahead to 2024, Florent predicts the future of AI in pharmaceuticals, anticipating a period of refinement and differentiation in the industry. Learn about the strategic role AI can play in revolutionizing drug development and commercialization.---🔑 Key Takeaways from this Episode:- A strategic approach is crucial for navigating the AI landscape in pharmaceuticals.- Align marketing efforts with the practical needs of sales teams for optimal collaboration.- Tailor sales approaches based on product complexity, with in-house teams for specialized products.- Embrace AI-generated personas and product-focused AI "buddies" to enhance customer relationships.- Prepare for the future by strategically incorporating AI to revolutionize drug development processes.🚀 Conclusion:Thank you for joining us on this insightful journey into the world of pharmaceutical sales and marketing. We hope you gained valuable perspectives from Florent Edouard and are inspired to embrace the transformative potential of artificial intelligence in the pharmaceutical realm. Stay tuned for more thought-provoking discussions on Pharma Sales and Tech podcast by Platforce!#aiinpharma, #aiprojects, #airevolution, #artificialintelligence, #customerexperience, #drugdiscovery, #futureofmedicine, #futuretrends, #healthcarerevolution, #healthcaretech, #healthtech, #innovativesolutions, #leadershipinsights, #medicaladvancements, #pharmaceuticals, #pharmainnovation, #pharmatech, #podcastinsights, #salesstrategies, #techinpharma
    Show More Show Less
    45 mins
  • The Intricacies of Pharma Sales, Technology, and Drug Market Access
    Dec 8 2023

    Welcome to another insightful episode of the Pharma Sales and Tech Podcast! In this edition, we're honored to have Dr. Rashmi Upadhyay, ur expert guest Driving Strategy and Marketing Excellence in Pharma and Biopharma, sharing her wealth of knowledge on pharmaceutical sales, market access strategies, and the evolving technological landscape within the industry.


    🔍 Episode Highlights:
    Understanding the Pharma Market Landscape: Dive into the intricate dynamics of the pharmaceutical industry and gain a deeper understanding of its evolving landscape.

    Navigating the Indian Pharma Market: Dr. Rashmi sheds light on the challenges and opportunities in navigating the complex terrain of the Indian pharmaceutical market.

    The Journey of a Drug from Development to Market: Explore the intricate process of bringing a pharmaceutical product from development to successful market entry.

    The Impact of AI and Digital Transformation in Pharma: Uncover the transformative role of Artificial Intelligence and digital technologies in shaping the future of pharmaceuticals.

    Challenges in Introducing New Drugs to the Market: Delve into the complexities and hurdles faced by pharmaceutical companies when introducing new drugs to diverse markets.

    Advice for Pharma Companies Entering New Markets: Dr. Rashmi shares valuable insights and advice for pharmaceutical companies embarking on ventures into new markets.

    🔑 Key Takeaways from this Episode:

    1. Understanding regulatory requirements and conducting feasibility tests are crucial for successful market access of new drugs.
    2. Adapting products to the local market and considering demographic factors is essential for effective drug introduction.
    3. Targeted marketing strategies, transparency, and thought leadership are key to gaining the trust of HCPs and patients.
    4. Digital marketing, content marketing, and AI can enhance market access strategies and improve engagement with HCPs.


    🚀 Conclusion:

    Join us in this enlightening conversation as we explore the multifaceted world of pharmaceuticals with Dr. Rashmi Upadhyay. The episode highlights the critical aspects of regulatory compliance, the impact of AI, and the strategic approaches necessary for successful market entry. Stay tuned for a wealth of knowledge and practical advice for navigating the ever-evolving pharmaceutical landscape. 🎧

    #PharmaTechInsights #HealthcareStrategy #AIinPharma #MarketAccess #advocacy, #ai, #aiinhealthcare, #aiinpharma, #healthcareinnovation, #healthcarerelationships, #healthtechinsights, #machinelearning, #omnichannelstrategies, #pharmainnovation, #pharmapodcast, #pharmasales, #pharmatechpodcast, #regulatorychallenges, #targetedmarketing, #techtrends., #transparency 💊🚀


    Show More Show Less
    44 mins
  • Exploring Sales Strategies And Technology Advancements With Ranjeet Mishra
    Nov 17 2023

    Today, your host, Stefan, is diving deep into the dynamic world of pharma with a special guest, Ranjeet Mishra, co-founder of GoodHums—a company revolutionizing life sciences.


    In this enlightening conversation, Ranjeet shares his journey, from the inception of Good Arms in 2018 to navigating the complexities of the pharma landscape. Get ready for an exploration of cutting-edge sales strategies, industry trends, and the intriguing role of technologies like ChatGPT in healthcare.

    🔍 Episode Highlights:

    1. GoodHums Genesis: Ranjeet Mishra takes us on a journey, unraveling the inception story of Good Arms in 2018—a life science company focused on transformative medicines and point-of-care diagnostics.
    2. Sales Strategies Unveiled: Discover the secret behind successful sales in the pharma industry as Ranjeet introduces the concept of "brand per doctor" to optimize product and customer mix.
    3. Navigating Industry Trends: Ranjeet emphasizes the importance of staying informed about industry trends and technological advancements, showcasing how platforms like LinkedIn and consultancy services keep him ahead in the game.
    4. ChatGPT and Healthcare: Delve into the potential impact of ChatGPT in healthcare. Ranjeet shares his insights on how AI tools can enhance the capabilities of healthcare professionals without replacing human skills.
    5. Addressing Data Concerns: Explore the delicate balance between embracing new technologies like ChatGPT and concerns about data leakage and competition in the pharma industry.
    6. Ranjeet's Advice to Pharma Companies: Gain valuable advice from a seasoned professional as Ranjeet outlines crucial factors for success, including prioritizing people, staying tech-savvy, optimizing sales efficiency, and focusing on product development.



    💡 Key Takeaways:

    1. Discover GoodHums' mission to enhance treatment outcomes through point-of-care testing, especially in underserved semi-urban and rural areas.
    2. Uncover Ranjeet's insights into successful sales strategies, including the concept of "brand per doctor" for optimizing product and customer mix.
    3. Gain valuable perspectives on staying updated with industry trends and technology advancements, with a focus on leveraging platforms like LinkedIn.


    🎧 Conclusion:
    As the episode concludes, Ranjeet shares his views on emerging technologies like ChatGPT in healthcare and the delicate balance between automation and human skills. Stefan and Ranjeet exchange thoughts on data security concerns and the exciting potential for pharma companies to gain a first-mover advantage. Don't miss this insightful conversation and stay tuned for more pharma innovations!

    The future of pharma is now—let's explore it together! 🌐🔍🎧


    Show More Show Less
    19 mins

What listeners say about Everybody Hates Pharma

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.